Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia

Journal:

PLOS Medicine

Published:

2025-09-16

DOI:

10.1371/journal.pmed.1004711

Affiliations:

11

Authors:

18

Go to article

Institutions	Authors	Share
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	6.000000	0.35
Research Triangle Institute International (RTI International), United States of America (USA)	3.000000	0.18
University of Virginia (UVA), United States of America (USA)	1.000000	0.06
Tulane University, United States of America (USA)	1.000000	0.06
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	1.000000	0.06
NYU Langone Health, United States of America (USA)	1.000000	0.06
The University of New Mexico (UNM), United States of America (USA)	1.000000	0.06
Patient-Led Research Collaborative, United States of America (USA)	1.000000	0.06
RECOVER, United States of America (USA)	1.000000	0.06
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.06

Interested in Clinical Sciences?